a golden age of genetics
We are living in a renaissance for precision medicine. With the convergence of technology and biology, drug development is rapidly evolving in ways that will redefine the industry.
Diseases that were viewed as intractable just a few years ago, can now be traced to their fundamental biological underpinnings, revealing new insights that can guide potential new treatment approaches.
Still, the process of translating genetic insights into novel precision medicines is neither easy nor linear. It is a labyrinth of choices, trials, errors, retracing and experimentation.
Thus the derivation of our name, Maze Therapeutics.